| 3 0 (0%) | 12-31 19:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 3.5 | 1-year : | 4.09 |
| Resists | First : | 3 | Second : | 3.5 |
| Pivot price | 3 | |||
| Supports | First : | 2.99 | Second : | 2.99 |
| MAs | MA(5) : | 3 | MA(20) : | 3 |
| MA(100) : | 3 | MA(250) : | 2.66  |
|
| MACD | MACD : | 0  |
Signal : | 0 |
| %K %D | K(14,3) : | 100 | D(3) : | 100 |
| RSI | RSI(14): 79.1 | |||
| 52-week | High : | 3 | Low : | 0.55 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ TLMD ] has closed Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 3.01 - 3.02 | 3.02 - 3.03 |
| Low: | 2.95 - 2.97 | 2.97 - 2.99 |
| Close: | 2.97 - 3 | 3 - 3.03 |
SOC Telemed, Inc. provides acute care telemedicine services and technology to hospitals, health systems, physician groups, and government organizations in the United States. The company's Telemed IQ, a cloud-based software platform provides telemedicine solutions. Its telemedicine solutions include teleNeurology, telePulmonology, telePsychiatry, telecardiology, teleCritical Care (ICU), and other specialties. The company was founded in 2004 and is based in Herndon, Virginia. As of April 6, 2022, SOC Telemed, Inc. was taken private.
Mon, 04 Apr 2022
SOC Telemed Stockholders Approve Acquisition by Patient Square Capital - PR Newswire
Wed, 30 Mar 2022
SOC Telemed Reports Fourth Quarter and Full Year 2021 Financial and Operating Results - PR Newswire
Thu, 03 Feb 2022
VMAC Swings, Wag! Gets a SPAC Deal, and DeSPAC TLMD is Going Private at $3 - TheStreet
Thu, 03 Feb 2022
SOC Telemed to be Acquired by Patient Square Capital - PR Newswire
Fri, 12 Nov 2021
Is Soc Telemed Inc (TLMD) Stock About to Get Hot Friday? - InvestorsObserver
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 101 (M) |
| Shares Float | 48 (M) |
| Held by Insiders | 12.8 (%) |
| Held by Institutions | 73.2 (%) |
| Shares Short | 1,800 (K) |
| Shares Short P.Month | 1,830 (K) |
| EPS | -1.88 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.79 |
| Profit Margin | -77.2 % |
| Operating Margin | -71.3 % |
| Return on Assets (ttm) | -22.3 % |
| Return on Equity (ttm) | -98.2 % |
| Qtrly Rev. Growth | 76.3 % |
| Gross Profit (p.s.) | 0.19 |
| Sales Per Share | 0.79 |
| EBITDA (p.s.) | -0.52 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -39 (M) |
| Levered Free Cash Flow | -10 (M) |
| PE Ratio | -1.6 |
| PEG Ratio | 0 |
| Price to Book value | 1.66 |
| Price to Sales | 3.75 |
| Price to Cash Flow | -7.84 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|